Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
Chae-Yong KimSun Ha PaekDo-Hyun NamJong-Hee ChangYong-Kil HongJeong Hoon KimOh Lyong KimSe-Hyuk KimPublished in: Journal of neuro-oncology (2020)
Clinicaltrials.gov Identifier: NCT00916409.